News
The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.
AstraZeneca PLC closed 22.80% short of its 52-week high of £133.88, which the company reached on September 3rd.
AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...
By integrating foundation models into its R&D pipeline, AstraZeneca seeks to enable data-driven discovery methods.
A cautious market traded AstraZeneca stock down by more than 2% following the report, on a day when the S&P 500 index landed ...
AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...
London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...
London’s FTSE 100 was flat at 8,824.61 in quiet afternoon trade on Friday, with US markets closed for Independence Day.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback